Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
South Korea
· Delayed Price · Currency is KRW 973.00
-1,807.00 (-65.00%)
At close: Jun 24, 2025
KRX:002210 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2006 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 23, 2025 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2006 - 2005 |
| Market Capitalization | 23,240 | 24,633 | 24,810 | 26,238 | 21,826 | 36,502 | Upgrade
|
| Market Cap Growth | -81.59% | -0.71% | -5.45% | 20.22% | -40.21% | 54.87% | Upgrade
|
| Enterprise Value | - | 40,658 | 42,182 | 43,804 | 36,221 | 56,080 | Upgrade
|
| Last Close Price | 973.00 | 1371.34 | 1351.36 | 1359.95 | 1080.35 | 1914.43 | Upgrade
|
| PE Ratio | 10.10 | 14.48 | - | 46.16 | 5.97 | 13.74 | Upgrade
|
| PS Ratio | 0.30 | 0.31 | 0.35 | 0.38 | 0.35 | 0.61 | Upgrade
|
| PB Ratio | 0.39 | 0.41 | 0.42 | 0.39 | 0.32 | 0.79 | Upgrade
|
| P/TBV Ratio | 0.39 | 0.42 | 0.43 | 0.39 | 0.33 | 0.79 | Upgrade
|
| P/FCF Ratio | - | - | 8.74 | - | - | 30.36 | Upgrade
|
| P/OCF Ratio | - | - | 6.73 | - | - | 12.51 | Upgrade
|
| EV/Sales Ratio | - | 0.52 | 0.59 | 0.64 | 0.58 | 0.93 | Upgrade
|
| EV/EBITDA Ratio | - | 8.82 | - | 18.10 | 12.61 | 18.56 | Upgrade
|
| EV/EBIT Ratio | - | 13.10 | - | 39.66 | 24.38 | 36.05 | Upgrade
|
| EV/FCF Ratio | - | - | 14.87 | - | - | 46.65 | Upgrade
|
| Debt / Equity Ratio | 0.58 | 0.58 | 0.57 | 0.46 | 0.40 | 0.68 | Upgrade
|
| Debt / EBITDA Ratio | 7.57 | 7.57 | - | 12.93 | 9.42 | 10.39 | Upgrade
|
| Debt / FCF Ratio | - | - | 11.87 | - | - | 26.10 | Upgrade
|
| Asset Turnover | 0.62 | 0.62 | 0.56 | 0.54 | 0.55 | 0.60 | Upgrade
|
| Inventory Turnover | 3.06 | 3.06 | 2.83 | 2.47 | 2.49 | 2.42 | Upgrade
|
| Quick Ratio | 1.18 | 1.18 | 1.20 | 1.39 | 1.61 | 1.49 | Upgrade
|
| Current Ratio | 1.47 | 1.47 | 1.45 | 1.74 | 2.02 | 1.81 | Upgrade
|
| Return on Equity (ROE) | 2.85% | 2.85% | -12.36% | 0.84% | 6.42% | 6.04% | Upgrade
|
| Return on Assets (ROA) | 1.54% | 1.54% | -1.52% | 0.55% | 0.81% | 0.96% | Upgrade
|
| Return on Capital (ROIC) | 2.07% | 2.07% | -2.02% | 0.71% | 1.08% | 1.29% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.20% | 4.20% | -4.20% | 1.30% | 1.70% | 2.40% | Upgrade
|
| Earnings Yield | 7.32% | 6.91% | -31.66% | 2.17% | 16.75% | 7.28% | Upgrade
|
| FCF Yield | -13.01% | -12.28% | 11.44% | -21.89% | -3.58% | 3.29% | Upgrade
|
| Dividend Yield | - | - | - | 2.21% | 2.78% | 1.57% | Upgrade
|
| Payout Ratio | 31.14% | 31.14% | - | 95.83% | 14.90% | 25.81% | Upgrade
|
| Buyback Yield / Dilution | 2.59% | 1.98% | 0.79% | - | -4.39% | 11.41% | Upgrade
|
| Total Shareholder Return | 2.59% | 1.98% | 0.79% | 2.21% | -1.61% | 12.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.